Search research articles
Contact Us
Filters
Showing results (101-110 of 578) with videos related to
Page
of 58
Sort By:
American Journal of Physiology. Endocrinology and Metabolism
|
September 7, 2006
Adipose tissue in offspring of Lepr(db/+) mice: early-life environment vs. genotype
Suzan Lambin, Rita van Bree, Silvia Caluwaerts, et al.
Gynecologic Oncology
|
May 15, 2007
The "Leuven" dose-dense paclitaxel/carboplatin regimen in patients with recurrent ovarian cancer
Isabelle Cadron, Karin Leunen, Frédéric Amant, et al.
Current Opinion in Oncology
|
August 9, 2006
The management of borderline tumours of the ovary
Isabelle Cadron, Frederic Amant, Toon Van Gorp, et al.
Expert Review of Anticancer Therapy
|
July 24, 2013
Genetic changes in nonepithelial ovarian cancer
Els Van Nieuwenhuysen, Sandrina Lambrechts, Diether Lambrechts, et al.
Gynecologic Oncology
|
October 9, 2009
Application of proteomics in ovarian cancer: which sample should be used?
Isabelle Cadron, Toon Van Gorp, Dirk Timmerman, et al.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing
|
February 13, 2009
Supervised classification of array CGH data with HMM-based feature selection
Anneleen Daemen, Olivier Gevaert, Karin Leunen, et al.
Journal of Ovarian Research
|
November 10, 2019
Organoids of epithelial ovarian cancer as an emerging preclinical in vitro tool: a review
Sander Dumont, Ziga Jan, Ruben Heremans, et al.
Gynecologic Oncology
|
March 12, 2022
Mitigation and management strategies for ocular events associated with tisotumab vedotin
Stella K Kim, Paul Ursell, Robert L Coleman, et al.
Gynecologic Oncology
|
September 26, 2012
Neoadjuvant chemotherapy in advanced ovarian cancer: On what do we agree and disagree?
Ignace Vergote, Andreas du Bois, Frederic Amant, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
November 10, 2022
Transfusion use and effect on progression-free, overall survival, and quality of life in upfront treatment of advanced epithelial ovarian cancer: evaluation of the European Organization for Research and Treatment EORTC-55971 Cohort
Lauren Shore Prescott, Ignace Vergote, Charlotte C Sun, et al.
Page
of 58
Search research articles
Search
Showing results (101-110 of 578) with videos related to
Sort By:
Page
of 58
American Journal of Physiology. Endocrinology and Metabolism
|
September 7, 2006
Adipose tissue in offspring of Lepr(db/+) mice: early-life environment vs. genotype
Suzan Lambin, Rita van Bree, Silvia Caluwaerts, et al.
Gynecologic Oncology
|
May 15, 2007
The "Leuven" dose-dense paclitaxel/carboplatin regimen in patients with recurrent ovarian cancer
Isabelle Cadron, Karin Leunen, Frédéric Amant, et al.
Current Opinion in Oncology
|
August 9, 2006
The management of borderline tumours of the ovary
Isabelle Cadron, Frederic Amant, Toon Van Gorp, et al.
Expert Review of Anticancer Therapy
|
July 24, 2013
Genetic changes in nonepithelial ovarian cancer
Els Van Nieuwenhuysen, Sandrina Lambrechts, Diether Lambrechts, et al.
Gynecologic Oncology
|
October 9, 2009
Application of proteomics in ovarian cancer: which sample should be used?
Isabelle Cadron, Toon Van Gorp, Dirk Timmerman, et al.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing
|
February 13, 2009
Supervised classification of array CGH data with HMM-based feature selection
Anneleen Daemen, Olivier Gevaert, Karin Leunen, et al.
Journal of Ovarian Research
|
November 10, 2019
Organoids of epithelial ovarian cancer as an emerging preclinical in vitro tool: a review
Sander Dumont, Ziga Jan, Ruben Heremans, et al.
Gynecologic Oncology
|
March 12, 2022
Mitigation and management strategies for ocular events associated with tisotumab vedotin
Stella K Kim, Paul Ursell, Robert L Coleman, et al.
Gynecologic Oncology
|
September 26, 2012
Neoadjuvant chemotherapy in advanced ovarian cancer: On what do we agree and disagree?
Ignace Vergote, Andreas du Bois, Frederic Amant, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
November 10, 2022
Transfusion use and effect on progression-free, overall survival, and quality of life in upfront treatment of advanced epithelial ovarian cancer: evaluation of the European Organization for Research and Treatment EORTC-55971 Cohort
Lauren Shore Prescott, Ignace Vergote, Charlotte C Sun, et al.
Page
of 58